Sign in

Midwest AViDD Center at the University of Minnesota

@midwestavidd.bsky.social
12 followers 17 following 8 posts

Our mission at the Midwest Antiviral Drug Discovery (AViDD) Center is to quickly develop the next generation of antiviral drugs for pandemic-level viruses, including SARS-CoV-2, Ebola, Lassa, Dengue and Zika. midwestavidd.umn.edu

PostsRepliesMedia
Midwest AViDD Center at the University of Minnesota @midwestavidd.bsky.social · 09/09/2026
A new compound developed by @midwestavidd.bsky.social and published in @natcomms.nature.com is more than 100 times more potent than previously reported Ebola entry inhibitors and shows strong protection in a preclinical model. #antiviral #drugdiscovery med.umn.edu/news/researc...
med.umn.edu
Researchers discover highly potent compound that blocks Ebola virus entry
A University of Minnesota-led multi-institutional research team has discovered a highly potent small molecule that blocks Ebola virus entry by stabilizing the virus's entry protein and provides strong...
022
Midwest AViDD Center at the University of Minnesota @midwestavidd.bsky.social · 20/04/2026
A new paper published in PLOS Pathogens by the Midwest AViDD Center's Project 5 Helicase team shows that a novel benzamide anti-Zika compound has superior potency, and its target, #NS4B, could hold the key to pan-flavivirus therapeutic development. #zika #flavivirus dx.plos.org/10.1371/jour...
dx.plos.org
Discovery of a potent anti-Zika virus benzamide series targeting the viral protein NS4B
Author summary Since its pandemic spread in 2015–2016, Zika virus infection remains a significant public health threat worldwide. The virus can cause severe brain damage in developing babies and serio...
000
Midwest AViDD Center at the University of Minnesota @midwestavidd.bsky.social · 27/03/2026
Dr. Fang Li was interviewed by Infection Control today about his lab's @natureportfolio.nature.com study on how efficiently #Marburg enters human cells and what that means for outbreak preparedness. @fanglilabumn.bsky.social #drugdiscovery #ebola www.infectioncontroltoday.com/view/marburg...
infectioncontroltoday.com
Marburg Virus Entry Mechanism Reveals New Targets for Antivirals and Infection Prevention Strategies | Infection Control Today
New research shows the Marburg virus enters human cells far more efficiently than Ebola, highlighting increased outbreak risk and underscoring the need for rapid detection, strict infection control, a...
100
Midwest AViDD Center at the University of Minnesota @midwestavidd.bsky.social · 23/03/2026
Coverage of Midwest AViDD's Co-Director Fang Li's @natureportfolio.nature.com paper in the @startribune.com! @fanglilabumn.bsky.social #marburg #drugdiscovery #globalhealth #nanobodies www.startribune.com/u-of-m-resea...
startribune.com
Minnesota researchers work to tame one of world’s deadliest viruses
Marburg isn’t a household name like Ebola, but University of Minnesota researchers created a method for comparison and showed it 300 times more efficient at infecting human cells.
000
Reposted by Midwest AViDD Center at the University of Minnesota
Nature [Unofficial] @nature.com.web.brid.gy · 11/03/2026
nature.com
Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor
Nature, Published online: 11 March 2026; doi:10.1038/s41586-026-10240-0 Marburgvirus glycoprotein binds to the endosomal receptor NPC1 in a distinct orientation with higher affinity compared with Ebola virus glycoprotein, accompanied by fusion-relevant rearrangements, enabling more efficient viral entry.
011
Midwest AViDD Center at the University of Minnesota @midwestavidd.bsky.social · 13/03/2026
A discovery by the @midwestavidd.bsky.social Center published in @natureportfolio.nature.com shows that Marburg is 300 times more efficient at entering human cells than Ebola. The research also establishes a therapeutic path to combat infection. www.nature.com/articles/s41...
nature.com
Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor - Nature
Marburgvirus glycoprotein binds to the endosomal receptor NPC1 in a distinct orientation with higher affinity compared with Ebola virus glycoprotein, accompanied by fusion-relevant rearrangements...
000
Midwest AViDD Center at the University of Minnesota @midwestavidd.bsky.social · 10/02/2025
Find the impact of NIH dollars in your state www.unitedformedicalresearch.org/nih-in-your-...
010
Midwest AViDD Center at the University of Minnesota @midwestavidd.bsky.social · 04/02/2025
A new study by the Midwest AViDD Center reveals that Sudan ebolavirus glycoprotein binds to the human NPC1 receptor approximately 9 times more strongly than Ebola virus glycoprotein. midwestavidd.umn.edu/new-study-re...
midwestavidd.umn.edu
New Study Reveals How Sudan Virus Binds to Human Cells | Midwest Antiviral Drug Discovery (AViDD) Center
010